The impact of the entry of biosimilars : evidence from Europe
Year of publication: |
2018
|
---|---|
Authors: | Scott Morton, Fiona ; Stern, Ariel D. ; Stern, Scott |
Published in: |
Review of industrial organization : RIO. - Dordrecht [u.a.] : Springer Science + Business Media B.V., ISSN 0889-938X, ZDB-ID 638140-6. - Vol. 53.2018, 1, p. 173-210
|
Subject: | Health care | Biosimilars | Biologics | Pharmaceutical competition | Health care spending | Innovation | Gesundheitskosten | Health care costs | Arzneimittel | Pharmaceuticals | EU-Staaten | EU countries | Markteintritt | Market entry | Wettbewerb | Competition | Pharmaindustrie | Pharmaceutical industry | Europa | Europe | Gesundheitswesen | Health care system | Pharmakologie | Pharmacology |
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
-
Bayerlein, Michael, (2023)
-
Compulsory licensing as a remedy against excessive pricing of life-saving medicines
Kianzad, Behrang, (2024)
- More ...
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
-
Will the stork return to Europe and Japan? : understanding fertility within development nations
Feyrer, James Donald, (2008)
-
Feyrer, James Donald, (2007)
- More ...